Cohen & Steers (CNS) Stock: Buy, Sell, or Hold?
CNS - Cohen & Steers Inc.
$72.07
1.81 (2.58%)
▲
5d:
+4.48%
30d:
-4.47%
90d:
-11.41%
BUY
HIGH Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Oct 15, 2026
0d
Get Alerted When CNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CNS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: CNS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$90.55
Based on 5.1% avg growth
INTRINSIC VALUE TODAY
$56.23
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNS is currently trading at $72.07, which is considered fair relative to its 30-day fair value range of $69.68 to $74.21. The stock's valuation (Forward PE: 19.3) is in line with its historical norms (18.9). At these levels, the market is pricing in 0.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNS is in a downtrend. The price is approaching resistance at $72.67. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CNS scores 82/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CNS is in a downtrend. The price is approaching resistance at $72.67. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CNS scores 82/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$69.68 -
$74.21
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (82/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($71.67)
- NEUTRAL: Market pricing in 0.7% annual earnings growth - fairly valued
- BULLISH: Bottoming setup score 82/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$69.68 -
$74.21
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$65.08
Resistance Level
$72.67
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.29
Wall Street Target
$71.67
(-0.6%)
Revenue Growth (YoY)
11.1%
Profit Margin
28.2%
Valuation Premium vs History
+0.7% premium
PE vs Historical
19.3 vs 18.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.7%
(market-implied from PE analysis)
1-Year Target
$72.57
(+1%)
2-Year Target
$73.08
(+1%)
3-Year Target
$73.59
(+2%)
3-Yr Target (if PE normalizes)
(PE: 19→19)
PE COMPRESSION
$72.12
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 6.2%)
$88.78
(+23%)
Base:
(SPY PE: 19.3, Growth: 6.2%)
$86.22
(+20%)
Bear:
(PE: 16.4, Growth: 6.2%)
$73.28
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 21.62 | Current EPS (TTM): $3.25
Bull Case
$88.86
(+23%)
Analyst growth 15.0%, PE expands to 23.8
Base Case
$80.78
(+12%)
Market implied 15.0%, PE stable at 21.6
Bear Case
$47.78
(-34%)
Severe decline -20.0%, PE contracts to 18.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 7:27 PM ET
Data refreshes hourly during market hours. Next update: 8:27 PM
Data refreshes hourly during market hours. Next update: 8:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Asset Management Stocks
Top-rated stocks in Asset Management by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KKR
KKR & Co. Inc. |
STRONG BUY
23 analysts |
$122 | 68 BUY |
|
BX
Blackstone Group Inc |
BUY
24 analysts |
$140 | 64 BUY |
|
TPG
TPG Inc |
STRONG BUY
17 analysts |
$58 | 62 BUY |
|
BLK
BlackRock Inc |
STRONG BUY
18 analysts |
$1337 | 38 SELL |
|
CG
Carlyle Group Inc |
BUY
20 analysts |
$52 | 66 BUY |
